Pooled Nucleic Acid Testing to Identify Antiretroviral Treatment Failure During HIV Infection
Authors:
- Susanne MaySMSusanne May
- Anthony GamstAGAnthony Gamst
- Richard HaubrichRHRichard Haubrich
- Constance BensonCBConstance Benson
- Davey M SmithDSDavey M Smith
- 1 February 2010
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 53 (2) , 194-201
Abstract
Background: Pooling strategies have been used to reduce the costs of polymerase chain reaction-based screening for acute HIV infection in populations in which the prevalence of acute infection is low (less than 1%). Only limited research has been done for conditions in which the prevalence of screening positivity is higher (greater than 1%). Methods and Results: We present data on a variety of pooling strategies that incorporate the use of polymerase chain reaction-based quantitative measures to monitor for virologic failure among HIV-infected patients receiving antiretroviral therapy. For a prevalence of virologic failure between 1% and 25%, we demonstrate relative efficiency and accuracy of various strategies. These results could be used to choose the best strategy based on the requirements of individual laboratory and clinical settings such as required turnaround time of results and availability of resources. Conclusions: Virologic monitoring during antiretroviral therapy is not currently being performed in many resource-constrained settings largely because of costs. The presented pooling strategies may be used to significantly reduce the cost compared with individual testing, make such monitoring feasible, and limit the development and transmission of HIV drug resistance in resource-constrained settings. They may also be used to design efficient pooling strategies for other settings with quantitative screening measures.Keywords
This publication has 43 references indexed in Scilit:
- Pharmacy Refill Adherence Compared with CD4 Count Changes for Monitoring HIV-Infected Adults on Antiretroviral TherapyPLOS Medicine, 2008
- Running with Scissors: Using Antiretroviral Therapy without Monitoring Viral LoadClinical Infectious Diseases, 2008
- Optimizing Screening for Acute Human Immunodeficiency Virus Infection with Pooled Nucleic Acid Amplification TestsJournal of Clinical Microbiology, 2008
- Frequent detection of acute HIV infection in pregnant womenAIDS, 2007
- HIV-1 Viral Load Assays for Resource-Limited SettingsPLOS Medicine, 2006
- Transient rebounds of HIV plasma viremia are associated with the emergence of drug resistance mutations in patients on highly active antiretroviral therapyJournal of Infection, 2005
- Detection of Acute Infections during HIV Testing in North CarolinaNew England Journal of Medicine, 2005
- A Randomized Study of the Utility of Human Immunodeficiency Virus RNA Measurement for the Management of Antiretroviral TherapyClinical Infectious Diseases, 2001
- Suppression of Plasma Virus Load below the Detection Limit of a Human Immunodeficiency Virus Kit Is Associated with Longer Virologic Response than Suppression below the Limit of QuantitationThe Journal of Infectious Diseases, 1999
- Estimation of the prevalence of a rare disease, preserving the anonymity of the subjects by group testing: application to estimating the prevalence of aids antibodies in blood donorsJournal of Statistical Planning and Inference, 1989